Outcome of surgery for acromegaly performed by different surgeons: Importance of surgical experience

Pituitary

Volumn 8, Issue 2, 2005, Pages 93-97

  Erturk, Erdinc ^a   Tuncel, Ercan ^a   Kiyici, Sinem ^a   Ersoy, Canan ^a   Duran, Cevdet ^a   Imamoglu, Sazi ^a  

^a ULUDAG UNIVERSITY   (Turkey)

Author keywords

Acromegaly; Hypopituitarism; Octreotide; Transsphenoidal surgery

Indexed keywords

GROWTH HORMONE; OCTREOTIDE;

ACROMEGALY; ADULT; ARTICLE; BRAIN SURGERY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COMPETENCE; CORRELATION COEFFICIENT; FEMALE; FOLLOW UP; GAMMA KNIFE RADIOSURGERY; GLUCOSE TOLERANCE TEST; GROWTH HORMONE BLOOD LEVEL; HIGH RISK PATIENT; HUMAN; HYPOPHYSIS ADENOMA; HYPOPITUITARISM; INTERMETHOD COMPARISON; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTOPERATIVE CARE; POSTPRANDIAL STATE; PRIORITY JOURNAL; REMISSION; REOPERATION; RETROSPECTIVE STUDY; RISK ASSESSMENT; SURGICAL APPROACH; SURGICAL TECHNIQUE; TREATMENT FAILURE; TREATMENT OUTCOME;

ACROMEGALY; ADENOMA; ADULT; CLINICAL COMPETENCE; FEMALE; HUMAN GROWTH HORMONE; HUMANS; MALE; MIDDLE AGED; OCTREOTIDE; PITUITARY NEOPLASMS; REOPERATION; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 33644524135     PISSN: 1386341X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11102-005-3280-9     Document Type: Article

References (25)

1. Melmed S, Jackson I, Kleinberg D, Klibanski A. Current treatment guidelines for acromegaly. J Clin Endocrinol Metab 1998;83:2646-2652.
2. Holdaway IM, Rajasoorya CR, Gamble GD, Stewart AW. Long-term treatment outcome in acromegaly. Growth Horm IGF Res 2003;13:185-192.
3. Sheaves R, Jenkins P, Blackburn P, Huneidi AH, Afshar F, Medbak S, Grossman AB, Besser GM, Wass JA. Outcome of transsphenoidal surgery for acromegaly using strict criteria for surgical cure. Clin Endocrinol (Oxf) 1996;45:407-413.
4. Abosch A, Tyrrell JB, Lamborn KR, Hannegan LT, Applebury CB, Wilson CB. Transsphenoidal microsurgery for growth hormone-secreting pituitary adenomas:iNitial outcome and long-term results. J Clin Endocrinol Metab 1998;83:3409-3410.
5. Colao A, Ferone D, Marzullo P, Cappabianca P, Cirillo S, Boerlin V, Lancranjan I, Lombardi G. Long-term effects of depot long-acting somatostatin analog octreotide on hormone levels and tumor mass in acromegaly. J Clin Endocrinol Metab 2001;86:2779-2786.
6. Cozzi R, Attanasio R, Montini M, Pagani G, Lasio G, Lodrini S, Barausse M,Albizzi M, Dallabonzana D, Pedroncelli AM. Four-year treatment with octreotide-long-acting repeatable in 110 acromegalic patients: Predictive value of short-term results? J Clin Endocrinol Metab 2003;88:3090-3098.
7. Shimon I, Cohen ZR, Ram Z, Hadani M. Transsphenoidal surgery for acromegaly: Endocrinological follow-up of 98 patients. Neurosurgery 2001;48:1239-1243.
8. Gittoes NJ, Sheppard MC, Johnson AP, Stewart PM. Outcome of surgery for acromegaly-the experience of a dedicated pituitary surgeon. QJM 1999;92:741-745.
9. Fahlbusch R, Honegger J, Buchfelder M. Evidence supporting surgery as treatment of choice for acromegaly. J Endocrinol 1997;155(Suppl 1):S53-S55.
10. Lissett CA, Peacey SR, Laing I, Tetlow L, Davis JR, Shalet SM. The outcome of surgery for acromegaly: The need for a specialist pituitary surgeon for all types of growth hormone (GH) secreting adenoma. Clin Endocrinol (Oxf) 1998;49:653-657.
11. Long H, Beauregard H, Somma M, Comtois R, Serri O, Hardy J. Surgical outcome after repeated transsphenoidal surgery in acromegaly. J Neurosurg 1996;85:239-247.
12. Swearingen B, Barker FG IInd, Katznelson L, Biller BM, Grinspoon S, Klibanski A, Moayeri N, Black PM, Zervas NT. Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly. J Clin Endocrinol Metab 1998;83:3409-3410.
13. Abe T, Ludecke DK. Recent results of secondary transnasal surgery for residual or recurring acromegaly. Neurosurgery 1998;42:1013-1021.
14. Barrande G, Pittino-Lungo M, Coste J, Ponvert D, Bertagna X, Luton JP, Bertherat J. Hormonal and metabolic effects of radiotherapy in acromegaly: Long-term results in 128 patients followed in a single center. J Clin Endocrinol Metab 2000;85:3779-3785.
15. Biermasz NR, Dulken HV, Roelfsema F. Postoperative radiotherapy in acromegaly is effective in reducing GH concentration to safe levels. Clin Endocrinol (Oxf) 2000;53:321-327.
16. Newman CB, Melmed S, George A, Torigian D, Duhaney M, Snyder P, Young W,Klibanski A, Molitch ME, Gagel R, Sheeler L, Cook D, Malarkey W, Jackson I,Vance ML, Barkan A, Frohman L, Kleinberg DL. Octreotide as primary therapy for acromegaly. J Clin Endocrinol Metab 1998;83:3031-3033.
17. Bevan JS, Atkin SL, Atkinson AB, Bouloux PM, Hanna F, Harris PE, James RA,McConnell M, Roberts GA, Scanlon MF, Stewart PM, Teasdale E, Turner HE, Wass JA, Wardlaw JM. Primary medical therapy for acromegaly: An open, prospective, multicenter study of the effects of subcutaneous and intramuscular slow-release octreotide on growth hormone, insulin-like growth factor-I, and tumor size. J Clin Endocrinol Metab 2002;87:4554-4563.
18. Ahmed S, Elsheikh M, Stratton IM, Page RC, Adams CB, Wass JA. Outcome of transphenoidal surgery for acromegaly and its relationship to surgical experience. Clin Endocrinol (Oxf) 1999;50:561-567.
19. Clayton RN. How many surgeons to operate on acromegalic patients? Clin Endocrinol (Oxf) 1999;50:557-559.
20. Attanasio R, Epaminonda P, Motti E, Giugni E, Ventrella L, Cozzi R, Farabola M, Loli P, Beck-Peccoz P, Arosio M. Gamma-knife radiosurgery in acromegaly: A 4-year follow-up study. J Clin Endocrinol Metab 2003;88:3105-3112.
21. Davis DH, Laws ER Jr, Ilstrup DM, Speed JK, Caruso M, Shaw EG, Abboud CF, Scheithauer BW, Root LM, Schleck C. Results of surgical treatment for growth hormone-secreting pituitary adenomas. J Neurosurg 1993;79:70-75.
22. Orme SM, McNally RJ, Cartwright RA, Belchetz PE. Mortality and cancer incidence in acromegaly: A retrospective cohort study. United Kingdom Acromegaly Study Group. J Clin Endocrinol Metab 1998;83:2730-2734.
23. Bates AS, Van't Hoff W, Jones JM, Clayton RN. An audit of outcome of treatment in acromegaly. Q J Med 1993;86:293-299.
24. Holdaway IM, Rajasoorya C. Epidemiology of acromegaly. Pituitary 1999;2(1):29-41.
25. Biermasz NR, van Dulken H, Roelfsema F. Ten-year follow-up results of transsphenoidal microsurgery in acromegaly. J Clin Endocrinol Metab 2000;85:4596-4602.